Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of ATRA+ATO/RIF+venetoclax combination therapy in the treatment of adult acute promyelocytic leukemia

Yanping Zeng, Jinsong He, Jiesi Li, shanshan song, mengze hao, yujia zhai, yajuan liu, Yingchang Mi, zhangsong yan

Blood (2025) 146 (Supplement 1): 5217.

https://doi.org/10.1182/blood-2025-5217

Published: 2025

Journal Articles

Efficacy and safety of mini-CVD combined with venetoclax and azacitidine in acute leukemia of ambiguous lineage: A single-center retrospective study

Yan Li, Yue Shang, Kaiqi Liu, Yuntao Liu, Dong Lin, Jinsong He, Jiesi Li, Yanping Zeng, Hui Wei, Zhangsong Yan, Yingchang Mi

Blood (2025) 146 (Supplement 1): 6864.

https://doi.org/10.1182/blood-2025-6864

Published: 2025

Journal Articles

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qi Wang, Qiuling Li, Bo Hu, Kaiqi Liu, Yingchang Mi

Blood (2023) 142 (Supplement 1): 2895.

https://doi.org/10.1182/blood-2023-179087

Published: 2023

Journal Articles

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Kaiqi Liu, Xiaohui Suo, Guanchen Bai, Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qiuling Li, Bo Hu, Yingchang Mi

Blood (2023) 142 (Supplement 1): 4272.

https://doi.org/10.1182/blood-2023-179009

Published: 2023

Journal Articles

Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis

Yuhong Shi, Yumi Tohyama, Tomomi Kadono, Jinsong He, S. M. Shahjahan Miah, Ryoichi Hazama, Chisato Tanaka, Kaoru Tohyama, Hirohei Yamamura

Blood (2006) 107 (11): 4554–4562.

https://doi.org/10.1182/blood-2005-09-3616

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy and Safety of ATRA+ATO/RIF+venetoclax combination therapy in the treatment of adult acute promyelocytic leukemia

Efficacy and safety of mini-CVD combined with venetoclax and azacitidine in acute leukemia of ambiguous lineage: A single-center retrospective study

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis

Email alerts

ASH Publications

American Society of Hematology

Update search

Efficacy and Safety of ATRA+ATO/RIF+venetoclax combination therapy in the treatment of adult acute promyelocytic leukemia

Efficacy and safety of mini-CVD combined with venetoclax and azacitidine in acute leukemia of ambiguous lineage: A single-center retrospective study

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only